Literature DB >> 7535004

Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells.

W Durante1, L Liao, A I Schafer.   

Abstract

Experiments were performed to characterize the uptake of L-arginine in rat aortic smooth muscle cells (SMC) and to examine whether inducers of nitric oxide synthase (NOS) could regulate the transport of L-arginine into these cells. L-Arginine transport by SMC was saturable, Na+ independent, strongly inhibited in the presence of other cationic amino acids, and could be stimulated by preloading the cells with cationic amino acids. Kinetic studies revealed the presence of both a high [Michaelis constant (Km) approximately 125 microM] and low (Km approximately 1.4 mM) affinity L-arginine transporter. Treatment of vascular SMC with interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) resulted in parallel increases in L-arginine transport and nitric oxide (NO) synthesis, as measured by nitrite production. Increasing the concentration of IL-1 beta and TNF-alpha caused a progressive elevation in nitrite production but did not further stimulate L-arginine uptake. Treatment of SMC with the combination of TNF-alpha and interferon-gamma (IFN-gamma) synergistically enhanced nitrite release without having any additional effect on L-arginine transport. Both induction of L-arginine transport and NOS activity by these cytokines were blocked by cycloheximide. Finally, treatment of SMC with interferon-gamma and N6,2'-O-dibutyryl adenosine 3',5'-cyclic monophosphate selectively stimulated the formation of nitrite by SMC but had no effect on L-arginine transport. These results demonstrate that L-arginine transport by cultured vascular SMC is mediated by the system y+ carrier and that inducers of NOS differentially regulate the activity of this transporter.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535004     DOI: 10.1152/ajpheart.1995.268.3.H1158

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Interleukin-2 and concanavalin A upregulate a cat2 isoform encoding a high affinity L-arginine transporter in feline lymphocytes.

Authors:  B R Stevens; M Tellier; W Harvey; D H Feldman; J Bosworth
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

2.  Parallel regulation of arginine transport and nitric oxide synthesis by angiotensin II in vascular smooth muscle cells role of protein kinase C.

Authors:  M Rivera-Correa; P I Altieri; N Escobales
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

3.  Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide.

Authors:  S M Wileman; G E Mann; A R Baydoun
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport.

Authors:  Chunying Li; Wei Huang; M Brennan Harris; Jonathan M Goolsby; Richard C Venema
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

5.  Differential regulation of homocysteine transport in vascular endothelial and smooth muscle cells.

Authors:  Xiaohua Jiang; Fan Yang; Eugen Brailoiu; Hieronim Jakubowski; Nae J Dun; Andrew I Schafer; Xiaofeng Yang; William Durante; Hong Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09       Impact factor: 8.311

6.  Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase.

Authors:  J Hou; H Kato; R A Cohen; A V Chobanian; P Brecher
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 7.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

8.  Role of L-citrulline transport in nitric oxide synthesis in rat aortic smooth muscle cells activated with LPS and interferon-gamma.

Authors:  Samantha M Wileman; Giovanni E Mann; Jeremy D Pearson; Anwar R Baydoun
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.